The bill strengthens law enforcement and public‑health defenses against illicit pill and fentanyl production by imposing serialization, registration, reporting, and criminal penalties for tableting/encapsulating machines and parts—at the cost of substantial compliance obligations, business uncertainty, and potential impacts on legitimate manufacturing, trade, and patient supply chains.
General public and law enforcement: the bill gives authorities new tools (registration, serialization, tracking, and criminal penalties) to detect, trace, and disrupt illicit pill/fentanyl production using tableting/encapsulating machines and critical parts.
People at risk from illicit opioids and communities: registries, the ability to suspend/deny registrations, and clearer traceability can reduce unlawful production and support prosecutions, improving public health and safety.
Regulated businesses (manufacturers/importers/dealers): the bill establishes clearer compliance obligations, phased-in implementation, and administrative due-process protections so firms that follow the rules can lawfully operate and avoid criminal exposure.
Small businesses, manufacturers, importers, dealers, and taxpayers: comprehensive new registration, serialization, reporting, long record‑retention (10 years) and possible fees impose substantial compliance costs and ongoing administrative burdens.
Patients and healthcare providers: expanded reporting and compliance requirements risk slowing supply chains or raising costs for medications and medical supplies produced with affected machines.
Businesses and intermediaries: broad statutory definitions plus open-ended Attorney General rulemaking and reporting requirements raise rights and business‑confidentiality concerns, expand government access to proprietary data, and create legal uncertainty about what parts/equipment are covered.
Based on analysis of 7 sections of legislative text.
Requires registration, serialization, reporting, and recordkeeping for pill‑press and capsule machines and specified critical parts and makes violations criminal.
Creates a federal registration, serialization, reporting, and recordkeeping regime for pill‑press (tableting) and capsule‑filling (encapsulating) machines and specified “critical parts.” It requires manufacturers, distributors, importers, exporters, and dealers to register devices and parts with the Attorney General, affix permanent serial numbers when required, report transactions, keep records, and submit items to a national registry; it also makes violations criminal offenses and forbids removal or alteration of required serial numbers (with a delayed effective date and limited defenses). The Attorney General is given broad regulatory authority to define covered machines/parts, set reporting formats, implement the registry, and set enforcement timelines.
Official title: To amend the Controlled Substances Act to provide for the regulation of critical parts of tableting machines and encapsulating machines, and for other purposes.
Introduced February 6, 2025 by Melanie Ann Stansbury · Last progress February 6, 2025